85 related articles for article (PubMed ID: 25717256)
1. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma.
Wang JS; Jing CQ; Shan KS; Chen YZ; Guo XB; Cao ZX; Mu LJ; Peng LP; Zhou ML; Li LP
World J Gastroenterol; 2015 Feb; 21(7):2191-8. PubMed ID: 25717256
[TBL] [Abstract][Full Text] [Related]
2. Promotion of Sema4D expression by tumor-associated macrophages: Significance in gastric carcinoma.
Li H; Wang JS; Mu LJ; Shan KS; Li LP; Zhou YB
World J Gastroenterol; 2018 Feb; 24(5):593-601. PubMed ID: 29434448
[TBL] [Abstract][Full Text] [Related]
3. HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor.
Fillies T; Werkmeister R; van Diest PJ; Brandt B; Joos U; Buerger H
BMC Cancer; 2005 Jul; 5():84. PubMed ID: 16035955
[TBL] [Abstract][Full Text] [Related]
4. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
[TBL] [Abstract][Full Text] [Related]
5. Aurora-A activation, correlated with hypoxia-inducible factor-1α, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma.
Wan XB; Fan XJ; Huang PY; Dong D; Zhang Y; Chen MY; Xiang J; Xu J; Liu L; Zhou WH; Lv YC; Wu XY; Hong MH; Liu Q
Cancer Sci; 2012 Aug; 103(8):1586-94. PubMed ID: 22587416
[TBL] [Abstract][Full Text] [Related]
6. Circulating Semaphorin 4D as a Marker for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis.
Ha YJ; Han DW; Kim JH; Chung SW; Kang EH; Song YW; Lee YJ
Dis Markers; 2018; 2018():2318386. PubMed ID: 30538782
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-Inducible Factor-1α (HIF-1α) as a Factor to Predict the Prognosis of Spinal Chordoma.
He G; Liu X
Spine (Phila Pa 1976); 2024 May; 49(9):661-669. PubMed ID: 38251727
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of jumonji domain-containing protein 2B and hypoxia inducible factor-1α in non-Hodgkin lymphoma tissues in children].
Diao YQ; Wang J; Zhu XL; Chen J; Zheng Y; Jiang L; Liu YP; Dai RH; Yan YW
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Nov; 25(11):1150-1155. PubMed ID: 37990460
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of plasma soluble Sema4D in patients with heart failure.
Lu Q; Dong N; Wang Q; Yi W; Wang Y; Zhang S; Gu H; Zhao X; Tang X; Jin B; Wu Q; Brass LF; Zhu L
PLoS One; 2013; 8(5):e64265. PubMed ID: 23741311
[TBL] [Abstract][Full Text] [Related]
10. Conclusions of the SIGNAL study in Huntington and implications for treatment of other slowly progressive neurodegenerative diseases.
Zauderer M; Evans EE
Clin Transl Med; 2023 Feb; 13(2):e1169. PubMed ID: 36710564
[No Abstract] [Full Text] [Related]
11. Correlation of microscopic tumor extension with tumor microenvironment in esophageal cancer patients.
Igbo BT; Jentsch C; Linge A; Plesca I; Kuzay Y; Löck S; Kumaravadivel MS; Doms S; Stolz-Kieslich L; Pollack D; Brückmann S; Tittlbach H; Weitz J; Aust D; Apolle R; Schmitz M; Troost EGC
Strahlenther Onkol; 2024 May; ():. PubMed ID: 38727811
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy.
Wu JH; Li YN; Chen AQ; Hong CD; Zhang CL; Wang HL; Zhou YF; Li PC; Wang Y; Mao L; Xia YP; He QW; Jin HJ; Yue ZY; Hu B
EMBO Mol Med; 2020 Feb; 12(2):e10154. PubMed ID: 31943789
[TBL] [Abstract][Full Text] [Related]
13. Sema4D silencing increases the sensitivity of nivolumab to B16-F10 resistant melanoma via inhibiting the PI3K/AKT signaling pathway.
Zhang Z; Zhang D; Wang F; Liu J; Sun Y; Anuchapreeda S; Tima S; Xiao Z; Duangmano S
PeerJ; 2023; 11():e15172. PubMed ID: 37096066
[TBL] [Abstract][Full Text] [Related]
14. SEMA4D Knockdown Attenuates
Rezaeepoor M; Rashidi G; Pourjafar M; Mohammadi C; Solgi G; Najafi R
Biomed Res Int; 2021; 2021():8507373. PubMed ID: 34337054
[TBL] [Abstract][Full Text] [Related]
15. Effects of NRP1 on angiogenesis and vascular maturity in endothelial cells are dependent on the expression of SEMA4D.
Lyu Z; Jin H; Yan Z; Hu K; Jiang H; Peng H; Zhuo H
Int J Mol Med; 2020 Oct; 46(4):1321-1334. PubMed ID: 32945351
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of semaphorin 4D enhances chemosensitivity by increasing 5-fluorouracile-induced apoptosis in colorectal cancer cells.
Rashidi G; Rezaeepoor M; Mohammadi C; Solgi G; Najafi R
Mol Biol Rep; 2020 Sep; 47(9):7017-7027. PubMed ID: 32888127
[TBL] [Abstract][Full Text] [Related]
17. VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer.
Chen Y; Zhang L; Liu WX; Wang K
Cell Mol Biol Lett; 2018; 23():2. PubMed ID: 29308068
[TBL] [Abstract][Full Text] [Related]
18. Stage-specific treatment of colorectal cancer: A microRNA-nanocomposite approach.
Fadaka AO; Akinsoji T; Klein A; Madiehe AM; Meyer M; Keyster M; Sikhwivhilu LM; Sibuyi NRS
J Pharm Anal; 2023 Nov; 13(11):1235-1251. PubMed ID: 38174117
[TBL] [Abstract][Full Text] [Related]
19. Mediating immunosuppressive functions: a new perspective on the complex immunological properties of SEMA4D in the tumor microenvironment.
Zeng S; Zhang Z; Ye C; Wang J; Jing C; Li L
Front Oncol; 2023; 13():1171926. PubMed ID: 37287907
[TBL] [Abstract][Full Text] [Related]
20. γδ T cell costimulatory ligands in antitumor immunity.
McGraw JM; Witherden DA
Explor Immunol; 2022; 2(1):79-97. PubMed ID: 35480230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
